Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 33

1.

The BH3 mimetic compound BH3I-1 impairs mitochondrial dynamics and promotes stress response in addition to its pro-apoptotic key function.

Stucki D, Brenneisen P, Reichert AS, Stahl W.

Toxicol Lett. 2018 Oct 1;295:369-378. doi: 10.1016/j.toxlet.2018.07.017. Epub 2018 Jul 18.

PMID:
30031050
2.

Efficacy of Different Compositions of Cerium Oxide Nanoparticles in Tumor-Stroma Interaction.

Sack-Zschauer M, Karaman-Aplak E, Wyrich C, Das S, Schubert T, Meyer H, Janiak C, Seal S, Stahl W, Brenneisen P.

J Biomed Nanotechnol. 2017 Dec 1;13(12):1735-1746. doi: 10.1166/jbn.2017.2452.

PMID:
29490761
3.

Nanotherapy and Reactive Oxygen Species (ROS) in Cancer: A Novel Perspective.

Brenneisen P, Reichert AS.

Antioxidants (Basel). 2018 Feb 22;7(2). pii: E31. doi: 10.3390/antiox7020031.

4.

UVA-1 exposure in vivo leads to an IL-6 surge within the skin.

Schneider LA, Raizner K, Wlaschek M, Brenneisen P, Gethöffer K, Scharffetter-Kochanek K.

Exp Dermatol. 2017 Sep;26(9):830-832. doi: 10.1111/exd.13286. Epub 2017 Apr 11.

PMID:
28094867
5.

A three-dimensional skin equivalent reflecting some aspects of in vivo aged skin.

Diekmann J, Alili L, Scholz O, Giesen M, Holtkötter O, Brenneisen P.

Exp Dermatol. 2016 Jan;25(1):56-61. doi: 10.1111/exd.12866. Epub 2015 Nov 23.

PMID:
26440058
6.

Effect of Fe3O4 Nanoparticles on Skin Tumor Cells and Dermal Fibroblasts.

Alili L, Chapiro S, Marten GU, Schmidt AM, Zanger K, Brenneisen P.

Biomed Res Int. 2015;2015:530957. doi: 10.1155/2015/530957. Epub 2015 May 21.

7.

Redox-active cerium oxide nanoparticles protect human dermal fibroblasts from PQ-induced damage.

von Montfort C, Alili L, Teuber-Hanselmann S, Brenneisen P.

Redox Biol. 2015;4:1-5. doi: 10.1016/j.redox.2014.11.007. Epub 2014 Nov 22.

8.

A drug-induced accelerated senescence (DIAS) is a possibility to study aging in time lapse.

Alili L, Diekmann J, Giesen M, Holtkötter O, Brenneisen P.

Age (Dordr). 2014 Jun;36(3):9658. doi: 10.1007/s11357-014-9658-8. Epub 2014 May 16.

9.

Combination of conventional chemotherapeutics with redox-active cerium oxide nanoparticles--a novel aspect in cancer therapy.

Sack M, Alili L, Karaman E, Das S, Gupta A, Seal S, Brenneisen P.

Mol Cancer Ther. 2014 Jul;13(7):1740-9. doi: 10.1158/1535-7163.MCT-13-0950. Epub 2014 May 13.

10.

Fibroblast-to-myofibroblast switch is mediated by NAD(P)H oxidase generated reactive oxygen species.

Alili L, Sack M, Puschmann K, Brenneisen P.

Biosci Rep. 2014 Feb 1;34(1). pii: e00089. Print 2014 Feb 1.

11.

Downregulation of tumor growth and invasion by redox-active nanoparticles.

Alili L, Sack M, von Montfort C, Giri S, Das S, Carroll KS, Zanger K, Seal S, Brenneisen P.

Antioxid Redox Signal. 2013 Sep 10;19(8):765-78. doi: 10.1089/ars.2012.4831. Epub 2013 Jan 24.

12.

Combined cytotoxic and anti-invasive properties of redox-active nanoparticles in tumor-stroma interactions.

Alili L, Sack M, Karakoti AS, Teuber S, Puschmann K, Hirst SM, Reilly CM, Zanger K, Stahl W, Das S, Seal S, Brenneisen P.

Biomaterials. 2011 Apr;32(11):2918-29. doi: 10.1016/j.biomaterials.2010.12.056. Epub 2011 Jan 26.

PMID:
21269688
13.

Stromal resistance of fibroblasts against oxidative damage: involvement of tumor cell-secreted platelet-derived growth factor (PDGF) and phosphoinositide 3-kinase (PI3K) activation.

Werth C, Stuhlmann D, Cat B, Steinbrenner H, Alili L, Sies H, Brenneisen P.

Carcinogenesis. 2008 Feb;29(2):404-10. doi: 10.1093/carcin/bgm296. Epub 2008 Jan 3.

PMID:
18174235
14.

Post-translational processing of selenoprotein P: implications of glycosylation for its utilisation by target cells.

Steinbrenner H, Alili L, Stuhlmann D, Sies H, Brenneisen P.

Biol Chem. 2007 Oct;388(10):1043-51.

PMID:
17937618
15.

Tirilazad amelioriates extracellular effects of photooxidative stress by sealing the membrane of UVA irradiated human dermal fibroblasts.

Schneider LA, Dissemond J, Schwamborn E, Wlaschek M, Brenneisen P, Scharffetter-Kochanek K.

Eur J Dermatol. 2006 Sep-Oct;16(5):530-6.

PMID:
17101474
16.

Selenoprotein P protects endothelial cells from oxidative damage by stimulation of glutathione peroxidase expression and activity.

Steinbrenner H, Bilgic E, Alili L, Sies H, Brenneisen P.

Free Radic Res. 2006 Sep;40(9):936-43.

PMID:
17015273
17.

Enhancement of tumor invasion depends on transdifferentiation of skin fibroblasts mediated by reactive oxygen species.

Cat B, Stuhlmann D, Steinbrenner H, Alili L, Holtkötter O, Sies H, Brenneisen P.

J Cell Sci. 2006 Jul 1;119(Pt 13):2727-38. Epub 2006 Jun 6.

18.

Involvement of selenoprotein P in protection of human astrocytes from oxidative damage.

Steinbrenner H, Alili L, Bilgic E, Sies H, Brenneisen P.

Free Radic Biol Med. 2006 May 1;40(9):1513-23. Epub 2006 Jan 13.

PMID:
16632112
19.

Adaptive cellular protection against UVA-1-induced lipid peroxidation in human dermal fibroblasts shows donor-to-donor variability and is glutathione dependent.

Schneider LA, Dissemond J, Brenneisen P, Hainzl A, Briviba K, Wlaschek M, Scharffetter-Kochanek K.

Arch Dermatol Res. 2006 Jan;297(7):324-8. Epub 2005 Nov 18.

PMID:
16328346
20.

Selenium, oxidative stress, and health aspects.

Brenneisen P, Steinbrenner H, Sies H.

Mol Aspects Med. 2005 Aug-Oct;26(4-5):256-67. Review.

PMID:
16105679

Supplemental Content

Loading ...
Support Center